- Investigator, Laboratory of Translational Genomics
Dr. Brown received a Ph.D. in genetics from the George Washington University in Washington, D.C., in 2003. He conducted his postdoctoral training in the Laboratory of Dr. Jeffrey Trent at the Translational Genomic Research Institute (TGen) in Phoenix, Arizona. He subsequently went on to direct his own research program at TGen as an investigator from 2005 to 2010, and served as an adjunct professor in basic medical sciences at the Mayo Clinic Cancer Center, the University of Arizona College of Medicine, and Arizona State University from 2008 to 2010. His work at TGen involved the application of whole-genome familial linkage, candidate gene, and genome-wide association study (GWAS) approaches to identify genetic variants associated with melanoma susceptibility. In 2010, Dr. Brown joined the Laboratory of Translational Genomics (LTG) in the Division of Cancer Epidemiology and Genetics (DCEG) as a tenure-track investigator. His research focuses on the genetic underpinnings of melanoma susceptibility.
- (2019). A Dynamic Cis-Regulation Pattern Underlying Epithelial Ovarian Cancer Susceptibility. CANCER RESEARCH. 79(3), 439-440.
- (2019). Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis The Future of Quantitative Analysis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 199(1), 12-21.
- (2019). Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 200(9), 1146-1153.
- (2019). Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma. MELANOMA RESEARCH. 29(5), 483-490.
- (2019). Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses. Cell Reports. 29(3), 573-+.